Cargando…
Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease
Niemann-Pick Type C disease (NPC) is a rare metabolic disorder characterized by disruption of normal cholesterol trafficking within the cells of the body. There are no FDA approved treatments available for NPC patients. Recently, the cycloheptaglucoside 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) has s...
Autores principales: | Collins, Christopher J., Loren, Bradley P., Alam, Md Suhail, Mondjinou, Yawo, Skulsky, Joseph L., Chaplain, Cheyenne R., Haldar, Kasturi, Thompson, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408228/ https://www.ncbi.nlm.nih.gov/pubmed/28452365 http://dx.doi.org/10.1038/srep46737 |
Ejemplares similares
-
Influence of Molecular Structure on the In Vivo Performance
of Flexible Rod Polyrotaxanes
por: Collins, Christopher J., et al.
Publicado: (2016) -
Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice
por: Alam, Md. Suhail, et al.
Publicado: (2018) -
Lysosomal-specific Cholesterol Reduction by Biocleavable Polyrotaxanes for Ameliorating Niemann-Pick Type C Disease
por: Tamura, Atsushi, et al.
Publicado: (2014) -
Efficacy and ototoxicity of different cyclodextrins in Niemann–Pick C disease
por: Davidson, Cristin D., et al.
Publicado: (2016) -
Structure-function relationships of cholesterol mobilization from the endo-lysosome compartment of NPC1-deficient human cells by β-CD polyrotaxanes
por: Samaddar, Shayak, et al.
Publicado: (2022)